22 May 2013
Keywords: tularik, prices, equity, offering, drug, discovery, firm
Article | 17 November 2003
US drug discovery firm Tularik says that it has priced an offering of 6million shares of its common stock in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 November 2003
© 2013 thepharmaletter.com